×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Generation Bio Co. (GBIO) NASDAQ

$4.15 0.45 (12.16%)

Market Cap: $245.97M

As of 03/28/24 02:28 PM EDT. Market open.

(GBIO)

Generation Bio Co. (GBIO)
NASDAQ

$4.15
0.45 (12.16%)

Market Cap: $245.97M

As of 03/28/24 02:28 PM EDT. Market open.

Add to Portfolio

generation bio is creating a revolutionary new class of genetic medicines that deliver durable, high levels of gene expression and have drug-like properties, including ability to titrate to effect and re-dose. our unique genewave technology allows us to overcome the limitations of other approaches by delivering larger genes, including more sophisticated regulatory elements, and avoiding the ... read more

generation bio is creating a revolutionary new class of genetic medicines that deliver durable, high levels of gene expression and have drug-like properties, including ability to titrate to effect and re-dose. our unique genewave technology allows us to overcome the limitations of other approaches by delivering larger genes, including more sophisticated regulatory elements, and avoiding the immunogenicity which limits both the number of patients who can be treated and the ability to re-dose them over time. we are a community of creative problem-solvers and independent thinkers. we are guided by strong personal integrity, humility, and the collaborative, learning mindset required to create solutions for patients and their families. to learn more about our efforts to usher in a new generation in medicine, please visit www.generationbio.com or our twitter feed, @lifetimegenetx. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
176
Address
.
PRICE CHART FOR GENERATION BIO CO
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.97
Previous Close
$3.70
Days Range
$3.23 - $3.73
52 week range
$0.86 - $6.98
Volume
302,691
Avg. Volume (30 days)
276,198
Market Cap
$245.97M
Dividend Yield
-
P/E
-
Shares Outstanding
66,477,111
Open
$3.97
Previous Close
$3.70
Days Range
$3.23 - $3.73
52 week range
$0.86 - $6.98
Volume
302,691
Avg. Volume (30 days)
276,198
Market Cap
$245.97M
Dividend Yield
-
P/E
-
Shares Outstanding
66,477,111
FINANCIAL STATEMENTS FOR GENERATION BIO CO
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR GENERATION BIO CO
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Zimmermann TracyCHIEF DEVELOPMENT OFFICERJan 29, 2024 Option Exercise$1.901,4762,80449,164Jan 31, 2024, 04:30 PM
Kerr DouglasCHIEF MEDICAL OFFICERJan 29, 2024 Option Exercise$1.901,4762,804385,628Jan 31, 2024, 04:30 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERJan 15, 2024 Option Exercise$1.914,8979,35345,619Jan 17, 2024, 05:00 PM
Kerr DouglasCHIEF MEDICAL OFFICERJan 15, 2024 Option Exercise$1.914,8979,353382,083Jan 17, 2024, 05:00 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERJan 15, 2024 Option Exercise$1.914,8979,353243,773Jan 17, 2024, 05:00 PM
Norkunas MatthewCHIEF FINANCIAL OFFICERJan 15, 2024 Option Exercise$1.915,47810,46350,259Jan 17, 2024, 05:00 PM
MCDONOUGH GEOFFPRESIDENT AND CEOJan 15, 2024 Option Exercise$1.9115,43129,4731,319,732Jan 17, 2024, 05:00 PM
Samayoa PhillipCHIEF STRATEGY OFFICERJan 15, 2024 Option Exercise$1.913,0205,768112,948Jan 17, 2024, 05:00 PM
Paone AntoinetteCHIEF OPERATING OFFICERJan 15, 2024 Option Exercise$1.913,6376,94712,683Jan 17, 2024, 05:00 PM
Appelhans DannielleDirectorDec 08, 2023 Buy$1.797,36313,1807,363Dec 11, 2023, 04:30 PM
Appelhans DannielleDirectorDec 08, 2023 Buy$1.826371,15912,637Dec 11, 2023, 04:30 PM
Appelhans DannielleDirectorDec 04, 2023 Buy$1.5012,00018,00012,000Dec 06, 2023, 04:30 PM
Quinn Anthony G.DirectorDec 01, 2023 Buy$1.4188,495124,77888,495Dec 05, 2023, 04:30 PM
Rowland Charles A JrDirectorDec 04, 2023 Buy$1.50150,000225,000534,757Dec 05, 2023, 04:30 PM
Rowland Charles A JrDirectorDec 01, 2023 Buy$1.31192,960252,778384,757Dec 05, 2023, 04:30 PM
Nicholson Donald WilliamDirectorDec 01, 2023 Buy$1.44100,000144,000213,576Dec 05, 2023, 04:30 PM
Samayoa PhillipCHIEF STRATEGY OFFICEROct 15, 2023 Option Exercise$3.241,2113,924107,256Oct 17, 2023, 06:00 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICEROct 15, 2023 Option Exercise$3.242,1837,073234,539Oct 17, 2023, 06:00 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICEROct 15, 2023 Option Exercise$3.242,1837,07336,385Oct 17, 2023, 06:00 PM
Norkunas MatthewCHIEF FINANCIAL OFFICEROct 15, 2023 Option Exercise$3.242,6758,66739,932Oct 17, 2023, 06:00 PM
MCDONOUGH GEOFFPRESIDENT AND CEOOct 15, 2023 Option Exercise$3.2410,39533,6801,288,187Oct 17, 2023, 06:00 PM
Kerr DouglasCHIEF MEDICAL OFFICEROct 15, 2023 Option Exercise$3.242,1837,073370,404Oct 17, 2023, 06:00 PM
Paone AntoinetteCHIEF OPERATING OFFICEROct 15, 2023 Option Exercise$3.241,2113,9245,828Oct 17, 2023, 06:00 PM
Paone AntoinetteCHIEF OPERATING OFFICERAug 23, 2023 Sale$4.933,11615,3622,914Aug 25, 2023, 04:35 PM
Samayoa PhillipCHIEF STRATEGY OFFICERJul 15, 2023 Option Exercise$5.081,2116,152104,342Jul 18, 2023, 04:35 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERJul 15, 2023 Option Exercise$5.082,18311,090229,285Jul 18, 2023, 04:35 PM
Paone AntoinetteCHIEF OPERATING OFFICERJul 15, 2023 Option Exercise$5.081,2116,1526,030Jul 18, 2023, 04:35 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERJul 15, 2023 Option Exercise$5.082,18311,09031,131Jul 18, 2023, 04:35 PM
Norkunas MatthewCHIEF FINANCIAL OFFICERJul 15, 2023 Option Exercise$5.083,16616,08333,496Jul 18, 2023, 04:35 PM
MCDONOUGH GEOFFPRESIDENT AND CEOJul 15, 2023 Option Exercise$5.087,47637,9781,275,145Jul 18, 2023, 04:35 PM
Kerr DouglasCHIEF MEDICAL OFFICERJul 15, 2023 Option Exercise$5.082,18311,090365,150Jul 18, 2023, 04:35 PM
Paone AntoinetteCHIEF OPERATING OFFICERApr 25, 2023 Sale$4.612,91413,4340Apr 26, 2023, 04:16 PM
Samayoa PhillipCHIEF STRATEGY OFFICERApr 15, 2023 Option Exercise$4.501,2115,450101,428Apr 18, 2023, 04:24 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERApr 15, 2023 Option Exercise$4.502,1839,824224,031Apr 18, 2023, 04:22 PM
Paone AntoinetteCHIEF OPERATING OFFICERApr 15, 2023 Option Exercise$4.501,2115,4502,914Apr 18, 2023, 04:21 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERApr 15, 2023 Option Exercise$4.502,1839,82425,877Apr 18, 2023, 04:19 PM
Norkunas MatthewCHIEF FINANCIAL OFFICERApr 15, 2023 Option Exercise$4.502,1839,82425,877Apr 18, 2023, 04:17 PM
MCDONOUGH GEOFFPRESIDENT AND CEOApr 15, 2023 Option Exercise$4.506,87930,9561,256,068Apr 18, 2023, 04:16 PM
Kerr DouglasCHIEF MEDICAL OFFICERApr 15, 2023 Option Exercise$4.502,1839,824356,780Apr 18, 2023, 04:14 PM
Paone AntoinetteCHIEF OPERATING OFFICERJan 26, 2023 Sale$5.562,69514,9840Jan 27, 2023, 04:22 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERJan 15, 2023 Option Exercise$5.102,57813,14820,623Jan 18, 2023, 05:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERJan 15, 2023 Option Exercise$5.102,57813,148218,777Jan 18, 2023, 05:02 PM
Samayoa PhillipCHIEF STRATEGY OFFICERJan 15, 2023 Option Exercise$5.101,4307,29398,514Jan 18, 2023, 04:59 PM
Norkunas MatthewCHIEF FINANCIAL OFFICERJan 15, 2023 Option Exercise$5.102,57813,14820,623Jan 18, 2023, 04:57 PM
MCDONOUGH GEOFFPRESIDENT AND CEOJan 15, 2023 Option Exercise$5.108,12241,4221,239,510Jan 18, 2023, 04:54 PM
Kerr DouglasCHIEF MEDICAL OFFICERJan 15, 2023 Option Exercise$5.102,57813,148351,526Jan 18, 2023, 04:52 PM
Paone AntoinetteCHIEF OPERATING OFFICERJan 15, 2023 Option Exercise$5.101,4307,2932,695Jan 18, 2023, 04:50 PM
Paone AntoinetteCHIEF OPERATING OFFICERJan 10, 2023 Sale$4.571,8658,5230Jan 11, 2023, 04:25 PM
Samayoa PhillipCHIEF STRATEGY OFFICERJan 09, 2023 Sale$5.111,8659,53095,819Jan 10, 2023, 04:57 PM
Cooper Ronald Harold WilfredDirectorJan 05, 2023 Option Exercise$5.129,50048,6409,500Jan 09, 2023, 05:23 PM
Paone AntoinetteCHIEF OPERATING OFFICEROct 27, 2022 Sale$5.032,91414,6570Oct 28, 2022, 04:05 PM
Paone AntoinetteCHIEF OPERATING OFFICEROct 15, 2022 Option Exercise$5.611,2116,7942,914Oct 18, 2022, 04:46 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICEROct 15, 2022 Option Exercise$5.612,18412,25215,763Oct 18, 2022, 04:45 PM
Samayoa PhillipCHIEF STRATEGY OFFICEROct 15, 2022 Option Exercise$5.611,2116,79495,819Oct 18, 2022, 04:44 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICEROct 15, 2022 Option Exercise$5.612,18412,252213,917Oct 18, 2022, 04:43 PM
Kerr DouglasCHIEF MEDICAL OFFICEROct 15, 2022 Option Exercise$5.612,18412,252344,801Oct 18, 2022, 04:41 PM
Norkunas MatthewCHIEF FINANCIAL OFFICEROct 15, 2022 Option Exercise$5.612,18412,25215,763Oct 18, 2022, 04:40 PM
MCDONOUGH GEOFFPRESIDENT AND CEOOct 15, 2022 Option Exercise$5.6110,39558,3161,222,329Oct 18, 2022, 04:38 PM
Paone AntoinetteCHIEF OPERATING OFFICERSep 29, 2022 Sale$5.242,82814,8190Sep 30, 2022, 04:05 PM
Rowland Charles A JrDirectorSep 19, 2022 Buy$5.2615,75082,845191,797Sep 20, 2022, 04:16 PM
Paone AntoinetteCHIEF OPERATING OFFICERSep 15, 2022 Sale$5.324,61024,5252,828Sep 19, 2022, 05:33 PM
Rowland Charles A JrDirectorSep 16, 2022 Buy$5.4833,481183,476176,047Sep 19, 2022, 05:21 PM
Rowland Charles A JrDirectorSep 15, 2022 Buy$5.4117,14792,765142,566Sep 19, 2022, 05:21 PM
Rowland Charles A JrDirectorSep 14, 2022 Buy$5.305,60029,652125,419Sep 15, 2022, 04:07 PM
Rowland Charles A JrDirectorSep 13, 2022 Buy$5.2018,78497,752119,819Sep 15, 2022, 04:07 PM
MCDONOUGH GEOFFPRESIDENT AND CEOJul 15, 2022 Option Exercise$7.1814,150101,5971,209,286Jul 19, 2022, 04:22 PM
Kerr DouglasCHIEF MEDICAL OFFICERJul 15, 2022 Option Exercise$7.184,36731,355339,547Jul 19, 2022, 04:19 PM
Norkunas MatthewCHIEF FINANCIAL OFFICERJul 15, 2022 Option Exercise$7.184,36731,35510,509Jul 19, 2022, 04:16 PM
Paone AntoinetteCHIEF OPERATING OFFICERJul 15, 2022 Option Exercise$7.182,42217,3907,438Jul 19, 2022, 04:14 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERJul 15, 2022 Option Exercise$7.184,36731,355208,663Jul 19, 2022, 04:11 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERJul 15, 2022 Option Exercise$7.184,36731,35510,509Jul 19, 2022, 04:09 PM
Nicholson Donald WilliamDirectorMar 10, 2022 Buy$4.718,12638,273113,576Mar 11, 2022, 04:53 PM
Nicholson Donald WilliamDirectorMar 09, 2022 Buy$4.792,29310,983105,450Mar 11, 2022, 04:53 PM
Rhodes Jason PDirectorSep 29, 2021 Sale$24.5916,586407,850608Sep 29, 2021, 07:16 PM
Rhodes Jason PDirectorSep 28, 2021 Sale$25.2413,113330,97216,556Sep 29, 2021, 07:16 PM
Rhodes Jason PDirectorSep 27, 2021 Sale$25.7051,3891,320,69729,645Sep 29, 2021, 07:16 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerSep 29, 2021 Sale$24.5930738608Sep 29, 2021, 07:15 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerSep 29, 2021 Sale$24.5916,556407,1120Sep 29, 2021, 07:15 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerSep 28, 2021 Sale$25.2424606638Sep 29, 2021, 07:15 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerSep 28, 2021 Sale$25.2413,089330,36616,556Sep 29, 2021, 07:15 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerSep 27, 2021 Sale$25.70952,442662Sep 29, 2021, 07:15 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerSep 27, 2021 Sale$25.7051,2941,318,25629,645Sep 29, 2021, 07:15 PM
Rhodes Jason PDirectorSep 24, 2021 Sale$25.8428,916747,16180,939Sep 24, 2021, 09:02 PM
Rhodes Jason PDirectorSep 23, 2021 Sale$26.1375,4651,972,127109,802Sep 24, 2021, 09:02 PM
Rhodes Jason PDirectorSep 22, 2021 Sale$25.8930,617792,705185,126Sep 24, 2021, 09:02 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerSep 24, 2021 Sale$25.8428,862745,76580,939Sep 24, 2021, 08:59 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerSep 23, 2021 Sale$26.1375,3251,968,469109,802Sep 24, 2021, 08:59 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerSep 22, 2021 Sale$25.8930,560791,229185,126Sep 24, 2021, 08:59 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerSep 24, 2021 Sale$25.84541,395757Sep 24, 2021, 08:59 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerSep 23, 2021 Sale$26.131403,659811Sep 24, 2021, 08:59 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerSep 22, 2021 Sale$25.89571,476951Sep 24, 2021, 08:59 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERSep 14, 2021 Option Exercise$4.594,50020,655202,654Sep 16, 2021, 04:12 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERSep 14, 2021 Sale$28.074,500126,315198,154Sep 16, 2021, 04:12 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERSep 10, 2021 Option Exercise$4.593,00013,770201,154Sep 14, 2021, 04:02 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERSep 10, 2021 Sale$25.973,00077,910198,954Sep 14, 2021, 04:02 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERAug 23, 2021 Option Exercise$4.591,5006,885199,654Aug 25, 2021, 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERAug 23, 2021 Sale$25.041,50037,560198,154Aug 25, 2021, 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERAug 10, 2021 Option Exercise$4.591,5006,885199,654Aug 11, 2021, 04:20 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERAug 10, 2021 Sale$22.631,50033,943198,654Aug 11, 2021, 04:20 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERJul 12, 2021 Option Exercise$4.593,00013,770201,154Jul 14, 2021, 04:02 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERJul 12, 2021 Sale$25.033,00075,087199,854Jul 14, 2021, 04:02 PM
Kerr DouglasCHIEF MEDICAL OFFICERJul 08, 2021 Option Exercise$5.163,51818,153330,076Jul 12, 2021, 04:02 PM
Kerr DouglasCHIEF MEDICAL OFFICERJul 08, 2021 Sale$25.203,51888,670328,447Jul 12, 2021, 04:02 PM
Rhodes Jason PDirectorJun 24, 2021 Sale$25.8531,008801,6184,092Jun 28, 2021, 04:57 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerJun 24, 2021 Sale$25.86581,500616Jun 28, 2021, 04:56 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerJun 24, 2021 Sale$25.8530,950800,1194,092Jun 28, 2021, 04:56 PM
Rhodes Jason PDirectorJun 21, 2021 Sale$24.8463,8921,586,940155,708Jun 23, 2021, 08:27 PM
Rhodes Jason PDirectorJun 23, 2021 Sale$25.3662,6091,587,54859,281Jun 23, 2021, 08:27 PM
Rhodes Jason PDirectorJun 22, 2021 Sale$24.9558,5771,461,479118,651Jun 23, 2021, 08:27 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerJun 23, 2021 Sale$25.361162,942719Jun 23, 2021, 08:26 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerJun 23, 2021 Sale$25.3662,4931,584,60659,281Jun 23, 2021, 08:26 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerJun 22, 2021 Sale$24.951082,695829Jun 23, 2021, 08:26 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerJun 22, 2021 Sale$24.9558,4691,458,784118,651Jun 23, 2021, 08:26 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerJun 21, 2021 Sale$24.841182,931897Jun 23, 2021, 08:26 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerJun 21, 2021 Sale$24.8463,7741,584,009155,708Jun 23, 2021, 08:26 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERMay 27, 2021 Option Exercise$4.591,5006,885199,654May 28, 2021, 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERMay 27, 2021 Sale$34.051,50051,075198,154May 28, 2021, 04:05 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERApr 22, 2021 Option Exercise$4.592,50011,4752,500Apr 23, 2021, 04:05 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERApr 22, 2021 Sale$33.322,50083,3000Apr 23, 2021, 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERApr 22, 2021 Option Exercise$0.601,500900199,654Apr 23, 2021, 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERApr 21, 2021 Option Exercise$0.601,500900199,654Apr 23, 2021, 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERApr 22, 2021 Sale$34.031,50051,045198,154Apr 23, 2021, 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERApr 21, 2021 Sale$31.071,50046,605198,154Apr 23, 2021, 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERApr 16, 2021 Option Exercise$0.601,500900199,654Apr 20, 2021, 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERApr 16, 2021 Sale$28.031,50042,045198,154Apr 20, 2021, 04:05 PM
Rhodes Jason PDirectorApr 14, 2021 Sale$26.6123,413622,99512,874Apr 14, 2021, 08:20 PM
Rhodes Jason PDirectorApr 13, 2021 Sale$25.1643,1451,085,74430,767Apr 14, 2021, 08:20 PM
Rhodes Jason PDirectorApr 12, 2021 Sale$26.1574,1241,938,22977,329Apr 14, 2021, 08:20 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerApr 14, 2021 Sale$26.6123,413622,99512,874Apr 14, 2021, 08:19 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerApr 13, 2021 Sale$25.1643,1451,085,74430,767Apr 14, 2021, 08:19 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerApr 12, 2021 Sale$26.1574,1241,938,22977,329Apr 14, 2021, 08:19 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerApr 09, 2021 Sale$27.6143,6811,205,948142,814Apr 09, 2021, 08:54 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerApr 08, 2021 Sale$28.5043,5501,241,241187,554Apr 09, 2021, 08:54 PM
ATLAS VENTURE ASSOCIATES X, L.P.10% OwnerApr 07, 2021 Sale$28.5139,8641,136,671229,807Apr 09, 2021, 08:54 PM
Rhodes Jason PDirectorApr 09, 2021 Sale$27.6143,6811,205,948142,814Apr 09, 2021, 08:53 PM
Rhodes Jason PDirectorApr 08, 2021 Sale$28.5043,5501,241,241187,554Apr 09, 2021, 08:53 PM
Rhodes Jason PDirectorApr 07, 2021 Sale$28.5139,8641,136,671229,807Apr 09, 2021, 08:53 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERMar 10, 2021 Option Exercise$0.6010,5006,300208,654Mar 12, 2021, 04:03 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERMar 10, 2021 Sale$34.9710,500367,209204,104Mar 12, 2021, 04:03 PM
Kerr DouglasCHIEF MEDICAL OFFICERMar 05, 2021 Option Exercise$4.5911,26751,716337,825Mar 09, 2021, 04:05 PM
Kerr DouglasCHIEF MEDICAL OFFICERMar 05, 2021 Sale$31.4411,267354,267335,148Mar 09, 2021, 04:05 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERMar 03, 2021 Option Exercise$4.593,00013,7703,000Mar 05, 2021, 04:05 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERMar 03, 2021 Sale$41.383,000124,1400Mar 05, 2021, 04:05 PM
MCDONOUGH GEOFFPRESIDENT AND CEOMar 01, 2021 Sale$37.5810,000375,8011,202,690Mar 03, 2021, 04:10 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERMar 01, 2021 Option Exercise$4.592,50011,4752,500Mar 03, 2021, 04:10 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERMar 01, 2021 Sale$38.842,50097,0992,300Mar 03, 2021, 04:10 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERFeb 10, 2021 Option Exercise$0.6010,4006,240208,554Feb 12, 2021, 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERFeb 10, 2021 Sale$34.6010,400359,856205,925Feb 12, 2021, 04:05 PM
Kerr DouglasCHIEF MEDICAL OFFICERFeb 08, 2021 Option Exercise$4.5911,26751,716337,825Feb 10, 2021, 04:05 PM
Kerr DouglasCHIEF MEDICAL OFFICERFeb 08, 2021 Sale$33.3711,267375,954330,325Feb 10, 2021, 04:05 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERFeb 02, 2021 Option Exercise$4.592,50011,4752,500Feb 04, 2021, 04:05 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERFeb 02, 2021 Sale$33.052,50082,6250Feb 04, 2021, 04:05 PM
Angelino Mark D.CHIEF OPERATING OFFICERJan 15, 2021 Option Exercise$4.597,50034,425353,137Jan 20, 2021, 04:05 PM
Angelino Mark D.CHIEF OPERATING OFFICERJan 15, 2021 Sale$32.977,500247,273349,637Jan 20, 2021, 04:05 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERJan 14, 2021 Option Exercise$4.592,50011,4752,500Jan 15, 2021, 04:06 PM
Zimmermann TracyCHIEF DEVELOPMENT OFFICERJan 14, 2021 Sale$33.092,50082,7250Jan 15, 2021, 04:06 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERJan 14, 2021 Option Exercise$0.605,6303,378203,784Jan 15, 2021, 04:05 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERJan 14, 2021 Sale$32.545,630183,212200,944Jan 15, 2021, 04:05 PM
Kerr DouglasCHIEF MEDICAL OFFICERJan 11, 2021 Option Exercise$4.5911,26751,716337,825Jan 13, 2021, 04:07 PM
Kerr DouglasCHIEF MEDICAL OFFICERJan 11, 2021 Sale$27.5811,267310,768331,579Jan 13, 2021, 04:07 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERJan 11, 2021 Option Exercise$0.6014,8208,892212,974Jan 13, 2021, 04:06 PM
Stanton MatthewCHIEF SCIENTIFIC OFFICERJan 11, 2021 Sale$27.6914,820410,372206,705Jan 13, 2021, 04:06 PM
Nicholson Donald WilliamDirectorJan 11, 2021 Buy$24.504,08199,985103,157Jan 13, 2021, 04:05 PM
Rowland Charles A JrDirectorJan 11, 2021 Buy$24.5020,408499,996101,035Jan 13, 2021, 04:04 PM
Angelino Mark D.Chief Operating OfficerDec 15, 2020 Option Exercise$4.595,30124,332350,938Dec 17, 2020, 04:05 PM
Angelino Mark D.Chief Operating OfficerDec 15, 2020 Sale$34.985,301185,431346,537Dec 17, 2020, 04:05 PM
Stanton MatthewChief Scientific OfficerDec 10, 2020 Option Exercise$0.6010,5406,324208,694Dec 14, 2020, 04:05 PM
Stanton MatthewChief Scientific OfficerDec 10, 2020 Sale$37.6210,540396,499203,376Dec 14, 2020, 04:05 PM
Angelino Mark D.Chief Operating OfficerAug 14, 2020 Option Exercise$0.6062,56037,536345,637Aug 18, 2020, 04:07 PM
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.10% OwnerJun 16, 2020 Buy$19.001,100,00020,900,0002,112,546Jun 18, 2020, 06:02 PM
Invus Public Equities, L.P.10% OwnerJun 16, 2020 Buy$19.00800,00015,200,0002,814,191Jun 18, 2020, 06:01 PM
Rowland Charles A JrDirectorJun 16, 2020 Buy$19.0030,000570,00080,627Jun 18, 2020, 05:30 PM
Casdin Capital, LLC10% OwnerJun 16, 2020 Buy$19.00650,00012,350,0001,611,215Jun 18, 2020, 05:29 PM
Zone Healthcare Holdings, LLC10% OwnerJun 16, 2020 Buy$19.00400,0007,600,0001,918,819Jun 17, 2020, 05:00 PM
Seybold William10% OwnerJun 16, 2020 Buy$19.00400,0007,600,0001,918,819Jun 17, 2020, 04:59 PM
Flynn James E10% OwnerJun 16, 2020 Buy$19.00225,0004,275,0001,186,215Jun 16, 2020, 02:50 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Zimmermann TracyCHIEF DEVELOPMENT OFFICER01/29/20242,804
Kerr DouglasCHIEF MEDICAL OFFICER01/29/20242,804
Zimmermann TracyCHIEF DEVELOPMENT OFFICER01/15/20249,353
Kerr DouglasCHIEF MEDICAL OFFICER01/15/20249,353
Stanton MatthewCHIEF SCIENTIFIC OFFICER01/15/20249,353
Norkunas MatthewCHIEF FINANCIAL OFFICER01/15/202410,463
MCDONOUGH GEOFFPRESIDENT AND CEO01/15/202429,473
Samayoa PhillipCHIEF STRATEGY OFFICER01/15/20245,768
Paone AntoinetteCHIEF OPERATING OFFICER01/15/20246,947
Appelhans DannielleDirector12/08/202313,180
Appelhans DannielleDirector12/08/20231,159
Appelhans DannielleDirector12/04/202318,000
Quinn Anthony G.Director12/01/2023124,778
Rowland Charles A JrDirector12/04/2023225,000
Rowland Charles A JrDirector12/01/2023252,778
Nicholson Donald WilliamDirector12/01/2023144,000
Samayoa PhillipCHIEF STRATEGY OFFICER10/15/20233,924
Stanton MatthewCHIEF SCIENTIFIC OFFICER10/15/20237,073
Zimmermann TracyCHIEF DEVELOPMENT OFFICER10/15/20237,073
Norkunas MatthewCHIEF FINANCIAL OFFICER10/15/20238,667
MCDONOUGH GEOFFPRESIDENT AND CEO10/15/202333,680
Kerr DouglasCHIEF MEDICAL OFFICER10/15/20237,073
Paone AntoinetteCHIEF OPERATING OFFICER10/15/20233,924
Paone AntoinetteCHIEF OPERATING OFFICER08/23/202315,362
Samayoa PhillipCHIEF STRATEGY OFFICER07/15/20236,152
Stanton MatthewCHIEF SCIENTIFIC OFFICER07/15/202311,090
Paone AntoinetteCHIEF OPERATING OFFICER07/15/20236,152
Zimmermann TracyCHIEF DEVELOPMENT OFFICER07/15/202311,090
Norkunas MatthewCHIEF FINANCIAL OFFICER07/15/202316,083
MCDONOUGH GEOFFPRESIDENT AND CEO07/15/202337,978
Kerr DouglasCHIEF MEDICAL OFFICER07/15/202311,090
Paone AntoinetteCHIEF OPERATING OFFICER04/25/202313,434
Samayoa PhillipCHIEF STRATEGY OFFICER04/15/20235,450
Stanton MatthewCHIEF SCIENTIFIC OFFICER04/15/20239,824
Paone AntoinetteCHIEF OPERATING OFFICER04/15/20235,450
Zimmermann TracyCHIEF DEVELOPMENT OFFICER04/15/20239,824
Norkunas MatthewCHIEF FINANCIAL OFFICER04/15/20239,824
MCDONOUGH GEOFFPRESIDENT AND CEO04/15/202330,956
Kerr DouglasCHIEF MEDICAL OFFICER04/15/20239,824
Paone AntoinetteCHIEF OPERATING OFFICER01/26/202314,984
Zimmermann TracyCHIEF DEVELOPMENT OFFICER01/15/202313,148
Stanton MatthewCHIEF SCIENTIFIC OFFICER01/15/202313,148
Samayoa PhillipCHIEF STRATEGY OFFICER01/15/20237,293
Norkunas MatthewCHIEF FINANCIAL OFFICER01/15/202313,148
MCDONOUGH GEOFFPRESIDENT AND CEO01/15/202341,422
Kerr DouglasCHIEF MEDICAL OFFICER01/15/202313,148
Paone AntoinetteCHIEF OPERATING OFFICER01/15/20237,293
Paone AntoinetteCHIEF OPERATING OFFICER01/10/20238,523
Samayoa PhillipCHIEF STRATEGY OFFICER01/09/20239,530
Cooper Ronald Harold WilfredDirector01/05/202348,640
Paone AntoinetteCHIEF OPERATING OFFICER10/27/202214,657
Paone AntoinetteCHIEF OPERATING OFFICER10/15/20226,794
Zimmermann TracyCHIEF DEVELOPMENT OFFICER10/15/202212,252
Samayoa PhillipCHIEF STRATEGY OFFICER10/15/20226,794
Stanton MatthewCHIEF SCIENTIFIC OFFICER10/15/202212,252
Kerr DouglasCHIEF MEDICAL OFFICER10/15/202212,252
Norkunas MatthewCHIEF FINANCIAL OFFICER10/15/202212,252
MCDONOUGH GEOFFPRESIDENT AND CEO10/15/202258,316
Paone AntoinetteCHIEF OPERATING OFFICER09/29/202214,819
Rowland Charles A JrDirector09/19/202282,845
Paone AntoinetteCHIEF OPERATING OFFICER09/15/202224,525
Rowland Charles A JrDirector09/16/2022183,476
Rowland Charles A JrDirector09/15/202292,765
Rowland Charles A JrDirector09/14/202229,652
Rowland Charles A JrDirector09/13/202297,752
MCDONOUGH GEOFFPRESIDENT AND CEO07/15/2022101,597
Kerr DouglasCHIEF MEDICAL OFFICER07/15/202231,355
Norkunas MatthewCHIEF FINANCIAL OFFICER07/15/202231,355
Paone AntoinetteCHIEF OPERATING OFFICER07/15/202217,390
Stanton MatthewCHIEF SCIENTIFIC OFFICER07/15/202231,355
Zimmermann TracyCHIEF DEVELOPMENT OFFICER07/15/202231,355
Nicholson Donald WilliamDirector03/10/202238,273
Nicholson Donald WilliamDirector03/09/202210,983
Rhodes Jason PDirector09/29/2021407,850
Rhodes Jason PDirector09/28/2021330,972
Rhodes Jason PDirector09/27/20211,320,697
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner09/29/2021738
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner09/29/2021407,112
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner09/28/2021606
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner09/28/2021330,366
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner09/27/20212,442
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner09/27/20211,318,256
Rhodes Jason PDirector09/24/2021747,161
Rhodes Jason PDirector09/23/20211,972,127
Rhodes Jason PDirector09/22/2021792,705
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner09/24/2021745,765
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner09/23/20211,968,469
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner09/22/2021791,229
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner09/24/20211,395
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner09/23/20213,659
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner09/22/20211,476
Stanton MatthewCHIEF SCIENTIFIC OFFICER09/14/202120,655
Stanton MatthewCHIEF SCIENTIFIC OFFICER09/14/2021126,315
Stanton MatthewCHIEF SCIENTIFIC OFFICER09/10/202113,770
Stanton MatthewCHIEF SCIENTIFIC OFFICER09/10/202177,910
Stanton MatthewCHIEF SCIENTIFIC OFFICER08/23/20216,885
Stanton MatthewCHIEF SCIENTIFIC OFFICER08/23/202137,560
Stanton MatthewCHIEF SCIENTIFIC OFFICER08/10/20216,885
Stanton MatthewCHIEF SCIENTIFIC OFFICER08/10/202133,943
Stanton MatthewCHIEF SCIENTIFIC OFFICER07/12/202113,770
Stanton MatthewCHIEF SCIENTIFIC OFFICER07/12/202175,087
Kerr DouglasCHIEF MEDICAL OFFICER07/08/202118,153
Kerr DouglasCHIEF MEDICAL OFFICER07/08/202188,670
Rhodes Jason PDirector06/24/2021801,618
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner06/24/20211,500
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner06/24/2021800,119
Rhodes Jason PDirector06/21/20211,586,940
Rhodes Jason PDirector06/23/20211,587,548
Rhodes Jason PDirector06/22/20211,461,479
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner06/23/20212,942
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner06/23/20211,584,606
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner06/22/20212,695
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner06/22/20211,458,784
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner06/21/20212,931
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner06/21/20211,584,009
Stanton MatthewCHIEF SCIENTIFIC OFFICER05/27/20216,885
Stanton MatthewCHIEF SCIENTIFIC OFFICER05/27/202151,075
Zimmermann TracyCHIEF DEVELOPMENT OFFICER04/22/202111,475
Zimmermann TracyCHIEF DEVELOPMENT OFFICER04/22/202183,300
Stanton MatthewCHIEF SCIENTIFIC OFFICER04/22/2021900
Stanton MatthewCHIEF SCIENTIFIC OFFICER04/21/2021900
Stanton MatthewCHIEF SCIENTIFIC OFFICER04/22/202151,045
Stanton MatthewCHIEF SCIENTIFIC OFFICER04/21/202146,605
Stanton MatthewCHIEF SCIENTIFIC OFFICER04/16/2021900
Stanton MatthewCHIEF SCIENTIFIC OFFICER04/16/202142,045
Rhodes Jason PDirector04/14/2021622,995
Rhodes Jason PDirector04/13/20211,085,744
Rhodes Jason PDirector04/12/20211,938,229
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner04/14/2021622,995
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner04/13/20211,085,744
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner04/12/20211,938,229
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner04/09/20211,205,948
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner04/08/20211,241,241
ATLAS VENTURE ASSOCIATES X, L.P.10% Owner04/07/20211,136,671
Rhodes Jason PDirector04/09/20211,205,948
Rhodes Jason PDirector04/08/20211,241,241
Rhodes Jason PDirector04/07/20211,136,671
Stanton MatthewCHIEF SCIENTIFIC OFFICER03/10/20216,300
Stanton MatthewCHIEF SCIENTIFIC OFFICER03/10/2021367,209
Kerr DouglasCHIEF MEDICAL OFFICER03/05/202151,716
Kerr DouglasCHIEF MEDICAL OFFICER03/05/2021354,267
Zimmermann TracyCHIEF DEVELOPMENT OFFICER03/03/202113,770
Zimmermann TracyCHIEF DEVELOPMENT OFFICER03/03/2021124,140
MCDONOUGH GEOFFPRESIDENT AND CEO03/01/2021375,801
Zimmermann TracyCHIEF DEVELOPMENT OFFICER03/01/202111,475
Zimmermann TracyCHIEF DEVELOPMENT OFFICER03/01/202197,099
Stanton MatthewCHIEF SCIENTIFIC OFFICER02/10/20216,240
Stanton MatthewCHIEF SCIENTIFIC OFFICER02/10/2021359,856
Kerr DouglasCHIEF MEDICAL OFFICER02/08/202151,716
Kerr DouglasCHIEF MEDICAL OFFICER02/08/2021375,954
Zimmermann TracyCHIEF DEVELOPMENT OFFICER02/02/202111,475
Zimmermann TracyCHIEF DEVELOPMENT OFFICER02/02/202182,625
Angelino Mark D.CHIEF OPERATING OFFICER01/15/202134,425
Angelino Mark D.CHIEF OPERATING OFFICER01/15/2021247,273
Zimmermann TracyCHIEF DEVELOPMENT OFFICER01/14/202111,475
Zimmermann TracyCHIEF DEVELOPMENT OFFICER01/14/202182,725
Stanton MatthewCHIEF SCIENTIFIC OFFICER01/14/20213,378
Stanton MatthewCHIEF SCIENTIFIC OFFICER01/14/2021183,212
Kerr DouglasCHIEF MEDICAL OFFICER01/11/202151,716
Kerr DouglasCHIEF MEDICAL OFFICER01/11/2021310,768
Stanton MatthewCHIEF SCIENTIFIC OFFICER01/11/20218,892
Stanton MatthewCHIEF SCIENTIFIC OFFICER01/11/2021410,372
Nicholson Donald WilliamDirector01/11/202199,985
Rowland Charles A JrDirector01/11/2021499,996
Angelino Mark D.Chief Operating Officer12/15/202024,332
Angelino Mark D.Chief Operating Officer12/15/2020185,431
Stanton MatthewChief Scientific Officer12/10/20206,324
Stanton MatthewChief Scientific Officer12/10/2020396,499
Angelino Mark D.Chief Operating Officer08/14/202037,536
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.10% Owner06/16/202020,900,000
Invus Public Equities, L.P.10% Owner06/16/202015,200,000
Rowland Charles A JrDirector06/16/2020570,000
Casdin Capital, LLC10% Owner06/16/202012,350,000
Zone Healthcare Holdings, LLC10% Owner06/16/20207,600,000
Seybold William10% Owner06/16/20207,600,000
Flynn James E10% Owner06/16/20204,275,000
Load More Insider Transactions
FUNDS WITH A POSITION IN GENERATION BIO CO
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.3,168,4150.00013%-5.53%Other
YIHENG CAPITAL MANAGEMENT, L.P.1,666,1810.32%ExitedOther
GEODE CAPITAL MANAGEMENT, LLC1,077,9630.00019%6.54%Other
RENAISSANCE TECHNOLOGIES LLC689,4000.00176%119%Other
D. E. SHAW & CO., INC.283,1080.00041%1033.07%Other
CHANGE IN SHARES OUTSTANDING FOR GENERATION BIO CO
STOCK BUYBACKS FOR GENERATION BIO CO
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.26%
1Q
12/31/2023
06/30/2023
0.64%
2Q
12/31/2023
03/31/2023
9.71%
3Q
12/31/2023
12/31/2022
11.21%
4Q
12/31/2023
09/30/2022
12.24%
5Q
12/31/2023
06/30/2022
15.63%
6Q
12/31/2023
03/31/2022
15.94%
7Q
12/31/2023
12/31/2021
16.22%
8Q
12/31/2023
09/30/2021
16.69%
9Q
12/31/2023
06/30/2021
17.33%
10Q
12/31/2023
03/31/2021
19.35%
11Q
12/31/2023
09/30/2020
45.33%
13Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.26%
1Q
06/30/2023
0.64%
2Q
03/31/2023
9.71%
3Q
12/31/2022
11.21%
4Q
09/30/2022
12.24%
5Q
06/30/2022
15.63%
6Q
03/31/2022
15.94%
7Q
12/31/2021
16.22%
8Q
09/30/2021
16.69%
9Q
06/30/2021
17.33%
10Q
03/31/2021
19.35%
11Q
09/30/2020
45.33%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR GENERATION BIO CO
LOADING...